Publication

Genomic Approaches to Posttraumatic Stress Disorder: The Psychiatric Genomic Consortium Initiative

Downloadable Content

Persistent URL
Last modified
  • 05/15/2025
Type of Material
Authors
    Caroline M. Nievergelt, University of California, San DiegoAllison E. Ashley-Koch, Duke UniversityShareefa Dalvie, University of Cape TownMicheal A. Hauser, Duke UniversityRajendra A. Morey, Duke UniversityAlicia K Smith, Emory UniversityMonica Uddin, University of Illinois
Language
  • English
Date
  • 2018-05-15
Publisher
  • Elsevier: 12 months
Publication Version
Copyright Statement
  • © 2018 Society of Biological Psychiatry
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0006-3223
Volume
  • 83
Issue
  • 10
Start Page
  • 831
End Page
  • 839
Grant/Funding Information
  • Financial support was provided by the Stanley Center for Psychiatric Genetics at the Broad Institute; One Mind; Cohen Veterans Bioscience; and the National Institute of Mental Health (NIMH) grants R01-MH111671-01 (RAM, AAK, MAH); and NIMH/U.S. Army Medical Research and Materiel Command support for R01MH106595 (CMN) and R01MH108826 (AKS, MU, CMN).
  • AAK and MAH were supported by the Department of Veterans Affairs’ (VA) Mid-Atlantic Mental Illness Research, Education, and Clinical Center (MIRECC); and the Research & Development and Mental Health Services of the Durham Veterans Affairs Medical Center.
Abstract
  • Posttraumatic stress disorder (PTSD) after exposure to a traumatic event is a highly prevalent psychiatric disorder. Heritability estimates from twin studies as well as from recent molecular data (single nucleotide polymorphism–based heritability) indicate moderate to high heritability, yet robust genetic variants for PTSD have not yet been identified and the genetic architecture of this polygenic disorder remains largely unknown. To date, fewer than 10 large-scale genome-wide association studies of PTSD have been published, with findings that highlight the unique challenges for PTSD genomics, including a complex diagnostic entity with contingency of PTSD diagnosis on trauma exposure and the large genetic diversity of the study populations. The Psychiatric Genomics Consortium PTSD group has brought together more than 200 scientists with the goal to increase sample size for genome-wide association studies and other genomic analyses to sufficient numbers where robust discoveries of molecular signatures can be achieved. The sample currently includes more than 32,000 PTSD cases and 100,000 trauma-exposed control subjects, and collection is ongoing. The first results found a significant shared genetic risk of PTSD with other psychiatric disorders and sex-biased heritability estimates with higher heritability in female individuals compared with male individuals. This review describes the scope and current focus of the Psychiatric Genomics Consortium PTSD group and its expansion from the initial genome-wide association study group to nine working groups, including epigenetics, gene expression, imaging, and integrative systems biology. We further briefly outline recent findings and future directions of “omics”-based studies of PTSD, with the ultimate goal of elucidating the molecular architecture of this complex disorder to improve prevention and intervention strategies.
Author Notes
  • Caroline Nievergelt, Ph.D., Department of Psychiatry, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0667, Tel. 858-246-1895, cnievergelt@ucsd.edu.
Keywords
Research Categories
  • Biology, Genetics
  • Health Sciences, Medicine and Surgery
  • Health Sciences, Mental Health

Tools

Relations

In Collection:

Items